Posted by ILADVOCATE on November 7, 2008, at 20:05:56
In reply to Re: glycine + memantine, posted by iladvocate on September 23, 2008, at 20:22:28
As follow up I learned that the Phase II glycine study is continuing all over the United States. I recieved correspondence back from Dr. Carpenter who is researching it in Maryland. Testimony was presented to Dr. Kane, director of psychiatry at Hillside Hospital. I recieved correspondence from the noted psychiatrist E. Fuller Torrey. And just today I recieved a full letter from the director of NAMI that they will be contacting my psychopharmcologist. And my psychopharmocologist who asked not to be named online but I can identify to any provider on the site who would have any questions allowed me to write to the director of the American Psychiatric Association and we both hope to recieve a word back. I'd like to thank the researchers who are studying the NDMA receptor modulates (what the glutaminergic agents are called technically) and their fine work in realizing what will be the future generation of antipsychotics. And as for glycine as it becomes more known by providers perhaps they will be interesting in initiating it into clinical practice. Although there are other novel classes of antipsychotics this is the most promising and considering that in gene studies people with schizophrenia were shown to be lacking in glutamate transmission this may be very well be a form of antipsychotic that will promote the full mental recovery I had without the risk of the synaptic brain damage that is tardive dyskinesia and what they are identifying in me as tardive psychosis (which is being treated with Zofran). And if people read this and are interesting in starting glycine it is available but please ask your provider but if your provider isn't familiar with it you can refer them to Dr. Javitt's study and as soon as mine is published it will be linked here too and perhaps they will consider it as an adjunct and depending on recovery rate possible as a primary, as a compound on its way to becoming the basis for a new generation of antipsychotics.
poster:ILADVOCATE
thread:850659
URL: http://www.dr-bob.org/babble/20081106/msgs/861377.html